ARSA and diabetes mellitus: In addition to ILD and malignancy, previous studies revealed several other risk factors for poor PM/DM outcomes, including delayed diagnosis, infection, thrombocytopenia, antisynthetase antibody (ASA) positivity, heart involvement and diabetes [2–6].